Veradermics, Incorporated (MANE)

NYSE: MANE · Real-Time Price · USD

60.85

-4.68 (-7.14%)

At close: Mar 30, 2026, 4:00 PM EDT

61.85

+1.00 (1.64%)

After-hours: Mar 30, 2026, 7:34 PM EDT

Veradermics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	10.28	3.5	2.35
Research & Development	62.07	23.28	14.97
Operating Expenses	72.35	26.78	17.32
Operating Income	-72.35	-26.78	-17.32
Interest Expense	-	-0.59	-0.04
Interest & Investment Income	1.56	0.48	0.87
Other Non Operating Income (Expenses)	0.79	0.39	-
Pretax Income	-70	-26.49	-16.49
Net Income	-70	-26.49	-16.49
Preferred Dividends & Other Adjustments	-	0.82	-
Net Income to Common	-70	-27.3	-16.49
Shares Outstanding (Basic)	1	1	1
Shares Outstanding (Diluted)	1	1	1
Shares Change (YoY)	1.64%	-	-
EPS (Basic)	-93.45	-37.05	-22.38
EPS (Diluted)	-93.45	-37.05	-22.38
EBIT	-72.35	-26.78	-17.32

Updated Jan 28, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q